home / stock / qsam / qsam short
Short Information | QSAM Biosciences Inc (OTCMKTS:QSAM)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 97,121 |
Total Actual Volume | 322,871 |
Short Trends | |
---|---|
Cover Days | 10 |
Short Days | 7 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 4,856 |
Average Short Percentage | 44.29% |
Is there a QSAM Short Squeeze or Breakout about to happen?
See the QSAM Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-02-2024 | $7.75 | $8.3 | $8.3 | $7.744 | 133,563 | 37,904 | 28.38% |
05-01-2024 | $7.8 | $7.75 | $7.8 | $7.7 | 36,481 | 5,000 | 13.71% |
04-29-2024 | $8 | $8 | $8.4 | $7.85 | 28,384 | 4,904 | 17.28% |
04-26-2024 | $8.09 | $8 | $8.39 | $7.9 | 18,914 | 5,153 | 27.24% |
04-25-2024 | $8.33 | $8.09 | $8.33 | $7.85 | 23,258 | 10,200 | 43.86% |
04-24-2024 | $8.34 | $8.25 | $8.34 | $8.2 | 13,392 | 2,700 | 20.16% |
04-23-2024 | $8 | $8.14 | $8.14 | $8 | 2,957 | 1,399 | 47.31% |
04-22-2024 | $8 | $8.14 | $8.14 | $8 | 3,155 | 704 | 22.31% |
04-19-2024 | $7.8 | $8.05 | $8.05 | $7.75 | 8,300 | 2,750 | 33.13% |
04-18-2024 | $7.56 | $7.78 | $7.88 | $7.47 | 12,068 | 2,959 | 24.52% |
04-17-2024 | $7.4 | $7.4 | $7.4 | $7.38 | 3,701 | 2,086 | 56.36% |
04-16-2024 | $7.4 | $7.4 | $7.4 | $7.29 | 4,116 | 515 | 12.51% |
04-15-2024 | $7.3 | $7.4 | $7.4 | $7.29 | 3,800 | 2,600 | 68.42% |
04-12-2024 | $7.25 | $7.4 | $7.4 | $7.25 | 10,389 | 6,089 | 58.61% |
04-11-2024 | $7.25 | $7.25 | $7.25 | $7.15 | 7,198 | 2,599 | 36.11% |
04-10-2024 | $7.3 | $7.25 | $7.3 | $7.22 | 1,600 | 1,300 | 81.25% |
04-09-2024 | $7.4 | $7.4 | $7.4 | $7.4 | 200 | 200 | 100% |
04-08-2024 | $7.4 | $7.4 | $7.4 | $7.4 | 811 | 810 | 99.88% |
04-05-2024 | $7.38 | $7.45 | $7.45 | $7.25 | 9,675 | 7,050 | 72.87% |
03-28-2024 | $7.5 | $7.5 | $7.6 | $7.5 | 909 | 199 | 21.89% |
News, Short Squeeze, Breakout and More Instantly...
QSAM Biosciences (OTCQB: QSAM) previously announced that it will effectuate a reverse stock split of the issued and outstanding shares of QSAM’s common stock, par value $0.0001 per share, at a ratio in the range of 1:1000 to 1:2000, prior to the closing of the merger between the company a...
Austin, TX, April 16, 2024 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc . (OTCQB: QSAM) (“ QSAM ” or the “ Company ”) previously announced that it will effectuate a reverse stock split of the issued and outstanding shares of QSAM’s common stock, par...
QSAM Biosciences (OTCQB: QSAM) , a clinical-stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment of bone cancer and other diseases and conditions, has signed a definitive agreement and plan of merger pr...